Abstract
Background: the successful treatment of spondylodiscitis (SD) and isolated spinal epidural empyema (ISEE) depends on early detection of causative pathogens, which is commonly performed either via blood cultures, intraoperative specimens, and/or image-guided biopsies. We evaluated the diagnostic sensitivity of these three procedures and assessed how it is influenced by antibiotics. Methods: we retrospectively analyzed data from patients with SD and ISEE treated surgically at a neurosurgery university center in Germany between 2002 and 2021. Results: we included 208 patients (68 [23–90] years, 34.6% females, 68% SD). Pathogens were identified in 192 cases (92.3%), including 187 (97.4%) pyogenic and five (2.6%) non-pyogenic infections, with Gram-positive bacteria accounting for 86.6% (162 cases) and Gram-negative for 13.4% (25 cases) of the pyogenic infections. The diagnostic sensitivity was highest for intraoperative specimens at 77.9% (162/208, p = 0.012) and lowest for blood cultures at 57.2% (119/208) and computed tomography (CT)-guided biopsies at 55.7% (39/70). Blood cultures displayed the highest sensitivity in SD patients (SD: 91/142, 64.1% vs. ISEE: 28/66, 42.4%, p = 0.004), while intraoperative specimens were the most sensitive procedure in ISEE (SD: 102/142, 71.8% vs. ISEE: 59/66, 89.4%, p = 0.007). The diagnostic sensitivity was lower in SD patients with ongoing empiric antibiotic therapy (EAT) than in patients treated postoperatively with targeted antibiotic therapy (TAT) (EAT: 77/89, 86.5% vs. TAT: 53/53, 100%, p = 0.004), whereas no effect was observed in patients with ISEE (EAT: 47/51, 92.2% vs. TAT: 15/15, 100%, p = 0.567). Conclusions: in our cohort, intraoperative specimens displayed the highest diagnostic sensitivity especially for ISEE, whereas blood cultures appear to be the most sensitive for SD. The sensitivity of these tests seems modifiable by preoperative EAT in patients with SD, but not in those with ISEE, underscoring the distinct differences between both pathologies.
Keywords: spondylodiscitis, isolated spinal epidural empyema, diagnostic sensitivity, blood culture, intraoperative specimen, computed tomography-guided biopsy
1. Introduction
Spondylodiscitis (SD) and isolated spinal epidural empyema (ISEE) are common types of primary spinal infections that are challenging to treat [1,2,3]. The reported incidence in the literature is five to six cases per 100,000 patient-years, but recent data suggests a higher incidence of 30/250,000 [4]. ISEE is an isolated infection of the epidural space with the accumulation of purulent substance without a concurrent SD, while SD refers to a primary infection of the intervertebral disc with secondary osteomyelitis of the adjacent endplates that occasionally occurs with epidural empyema [5,6].
Standardized treatment guidelines for SD and ISEE are currently lacking [7,8]. Surgical treatment followed by conservative management with antibiotic therapy takes several weeks and months for patients to recover. However, inadequate antibiotic therapy during this period can increase patient morbidity [9]. Reliable diagnostics including pathogen detection with antibiogram resistogram are indispensable for infection treatment. Three procedures are available for isolating causative pathogens, including blood cultures, intraoperative specimens, and computed tomography (CT)-guided biopsies.
Some studies suggest that blood cultures can yield early positive results due to hematogenous spreading of the infection, in particular in patients with SD [10]. To minimize a contamination, blood cultures need to be withdrawn from two or three different sites [11]. At least three pairs of blood cultures (aerobic and anaerobic culture medium) should be collected before the initiation of antibiotic therapy, irrespective of febrile temperatures [12]. This allows the isolation of a causative pathogen in up to 37.5% of cases [13].
Intraoperative sampling on site of the infectious focus is considered the most sensitive and specific method for pathogen detection [14]. CT-guided biopsy is an additional option to isolate pathogens, especially in cases when abscess formations such as psoas abscesses are visible on diagnostic imaging. However, the sensitivity of each procedure is limited when performed alone, whereas a combination of these procedures can increase the likelihood of successful pathogen detection [15,16].
In case of severe infections, empirical antibiotic therapy (EAT) is usually initiated preoperatively and then switched to targeted antibiotic therapy (TAT) after the causative pathogen has been identified, based on resistogram. Other cases are initially managed with TAT according to the resistogram [4].
A few studies have reported on the diagnostic sensitivity of these three procedures for SD and ISEE [12,17]. However, the impact of ongoing EAT on pathogen detection in SD and ISEE has not been thoroughly addressed. Therefore, this retrospective study aims to assess the diagnostic sensitivity of the three procedures and evaluate the influence of prior EAT on outcomes.
2. Materials and Methods
2.1. Study Design and Patient Data
A retrospective observational study was performed on a cohort of 208 consecutive patients with SD and ISEE who underwent surgical treatment at our neurosurgery department from 2002 to 2021. All surgically treated patients with SD or ISEE aged over 18 years and without intradural infection were included. The study was approved by the local ethics committee of Dresden university hospital (Reference number BO-EK-17012022). Patient data were identified and extracted via review of electronic medical records using the ORBIS system (ORBIS, Dedalus, Bonn, Germany) and neuroimaging files through the IMPAX system (IMPAX, Impax Asset Management Group plc, London, UK). Detailed demographic, clinical, radiological, laboratory and microbiological analyses were evaluated between groups.
2.2. Clinical Management
The diagnosis of SD or ISEE was obtained according to the Clinical Practice Guidelines for the diagnosis and treatment of native vertebral osteomyelitis in Adults of the Infectious Diseases Society of America (IDSA) [18]. Primary treatment was conservative with intravenous antibiotics in a conservative external or internal clinic, whereas the patient was referred to our clinic if surgical treatment was required, e.g., in cases with neurological deficits, spinal instability, or epidural abscess. Our cohort of 187 patients included surgical ISEE or SD patients with primary immediate indication for open surgery. Depending on disease severity, surgical therapy involved abscess evacuation, dorsal decompression with/without dorsal interbody fusion, ventral debridement with anterior cervical discectomy and fusion (ACDF), or vertebral body replacement. Surgical decision making was based on clinical experience and several defined radiographic signs. Patients undergoing spinal instrumentation had preoperative CT scans to assess bony integrity.
Patients with ISEE were treated with abscess evacuation with/without drainage or ACDF for abscesses ventral to the cervical spinal cord. Patients with SD underwent either abscess evacuation or/and instrumentation for instability, deformity, and pain-related immobility. In case of psoas abscess, drainage was performed CT-guided.
SD patients with a spinal epidural abscess without deformity underwent decompression with removal of the abscess and vertebral disc with/without dorsal interbody fusion. If the vertebral body height reduction was less than 50%, dorsal decompression with interbody fusion was performed first, and optionally with secondary ventral debridement with vertebral body replacement. In cases where vertebral body reduction was more than 50%, dorsal decompression with instrumentation followed by vertebral body replacement was performed.
2.3. Antibiotic Therapy
Each patient received either TAT or EAT, depending on the clinical condition at the time of admission and as recommended by the local infectious disease department. Our cohort included many patients with known infection who were already treated with antibiotics externally and presented to our clinic for surgical treatment. If antibiotics were continued or discontinued for less than 48 h, we defined this condition as being under ongoing antibiotic therapy and called this group EAT, whereas patients without antibiotic therapy or with an antibiotic-free period of more than 2 days formed the TAT group. EAT was switched to TAT after the identification of the pathogen. Intravenous antibiotic therapy was switched to oral antibiotics after approximately 4 weeks, and the total duration of antibiotic therapy was approximately 8 weeks.
2.4. Methods for Pathogen Detection
Blood cultures were preferably collected from all patients before starting antibiotic therapy, using three pairs of blood cultures at two or three different peripheral sites (aerobic and anaerobic media) for microbiological assessment. Some patients presented to our clinic in a septic condition with ongoing antibiotic therapy, thus blood culture collection in an antibiotic-free period was not possible, nor was antibiotic suspension justifiable in this case.
Intraoperatively obtained tissue was placed in Schaedler boullions (bioMérieux, Nürtingen, Germany) directly in the operating room and these were then sent to our institute of medical microbiology and virology for analysis. There, the boullions were first incubated at 37 degrees and examined for turbidity after 48 h. Once turbidity was detected, the culture suspension was plated out on Columbia Blood Agar (bioMérieux, Nürtingen, Germany) and HCB Agar (bioMérieux, Nürtingen, Germany). Aerobic culture growth was checked for the first time after 24 h and anaerobic culture growth after another 48 h.
CT-guided biopsy was performed exclusively in case of psoas abscess by the neuroradiologists or radiologists, whereas paravertebral dorsal abscesses and epidural empyema were managed during open surgery. All patients received a pre-interventional contrast-enhanced MRI of the spine and an additional CT for planning. A psoas abscess was always observed on contrast-enhanced MRI of the spine and classified by the neuroradiologist or radiologist as a formation with fluid-equivalent signal intensity and biopsy-worthy formation. An abscess was defined as iso- or hypointense on T1-weighted images, with fluid-equivalent signal intensity on T2-weighted images, and with edge enhancement on contrast-enhanced T1-weighted fat-saturated images [19]. Our cohort did not include CT-guided biopsy of disc, vertebral body, dorsal paravertebral abscess, or epidural abscess. The approach was chosen based on anatomic considerations and the predominant site of the infective lesions. The liquefied contents of the abscess were aspirated and sent for microbiological examination; in addition, a sample was fixed in formalin for pathohistological analysis. In our study, 128 patients (61.5%) were diagnosed with psoas abscess, of which 70 patients (54.7%) were tappable, 50 patients had SD, and 20 had ISEE. Following CT-guided sampling, all patients received a suction-irrigation drainage system from which samples were collected two times daily, and the abscess cavity was also irrigated with gentamycin or vancomycin two times daily, depending on the resistogram. After obtaining three pathogen-free results from the suction-irrigation drainage samples, the drainage was removed.
2.5. Microbiological Assessment
Bacteria with high to moderate pathogenic potential that are unlikely to present as contaminants, such as methicillin-susceptible staphylococcus aureus (MSSA), were deemed significant if they were detected in at least one culture. However, potentially low pathogenic bacteria, e.g., cutibacterium, were only considered clinically significant if they were identified in at least two independent cultures. Cases with negative microbiologic results, but with clear clinical and radiographic evidence of SD or ISEE, were classified as positive with non-identified pathogens.
2.6. Case Presentation
This following figure presented a case from our series showing our clinical management of spondylodiscitis (Figure 1).
2.7. Statistical Analysis
Data were statistically analyzed with the SPSS software package (SPSS Statistics 28, IBM, Armonk, New York, NY, USA). Descriptive statistics were used, and categorical variables were adjusted by Fisher exact tests or chi-square tests where appropriate. Numerical variables were analyzed with Mann-Whitney U tests. A binomial test was also used. All statistical tests were two-sided, and a value p < 0.05 was considered statistically significant. The sensitivity of a method was calculated as follows: S = true positive/(true positive + false negative) [20].
3. Results
3.1. Demographics and Baseline Characteristics
We enrolled 208 patients (males: 136, 65.4% vs. females: 72, 34.6%, p < 0.001) aged 68 [23–90] y, median [interquartile range] with SD (142, 68.3%) and ISEE (66, 31.7%). Intraoperative specimens and blood cultures were obtained in all cases, while computed tomography (CT)-guided biopsies were performed in 70 tappable cases (54.7%) of 128 patients with psoas abscess (61.5%). A causative pathogen was isolated in 192 cases (92.3%), of which 187 cases (97.4%) presented a pyogenic pathogen and five cases (2.4%) a non-pyogenic pathogen. Gram-positive pathogens were detected in 162 of 187 cases (86.6%), whereas a Gram-negative pathogen was identified in only 25 cases (13.4%). Empiric antibiotic therapy (EAT) was initiated preoperatively in 140 patients (67.3%) and switched following pathogen detection, whereas targeted antibiotic therapy (TAT) was started postoperatively according to resistogram in 68 patients (32.7%). Twelve patients (6%) died due to the disease and its complications (Table 1).
Table 1.
Baseline Characteristics | N = 208 | Percentage |
---|---|---|
Male | 136 | 65.4% |
Female | 72 | 34.6% |
Age | 68 [23–90] y * | - |
Spondylodiscitis | 142 | 68.3% |
Isolated spinal epidural empyema | 66 | 31.7% |
Surgery | 208 | 100% |
Blood cultures | 208 | 100% |
Psoas abscess | 128 | 61.5% |
CT-guided biopsy of Psoas | 70/128 | 54.7% |
Known causative pathogens | 192 | 92.3% |
Unknown causative pathogens | 16 | 7.7% |
Pyogenic spinal infection | 187/192 | 97.4% |
Non-pyogenic spinal infection | 5/192 | 2.6% |
Gram-positive pathogens | 162/187 | 86.6% |
Gram-negative pathogens | 25/187 | 13.4% |
Empiric antibiotic therapy | 140 | 67.3% |
Targeted antibiotic therapy | 68 | 32.7% |
Duration of intravenous antibiotics | 4 [3–6] w * | - |
Duration of antibiotics | 8 [6–12] w * | - |
Death | 12 | 5.8% |
CT: computer tomography, *: median [interquartile range].
Ages, sex, diabetes mellitus, immunosuppression, and obesity are the most known risk factors in SD and ISEE. In our cohort, diabetes mellitus was observed in 70 patients (37.4%), while 59 patients (31.6%) had a BMI (body mass index) over 30 kg/m2 and 27 patients (14.4%) were immunosuppressed.
Primary sources of infection were identified in 137 patients (73.3%); however, infections resulting directly from surgical spine procedures were not included in this study. We identified 37 skin infections (19.8), 17 infections after epidural application (9.1%), 16 respiratory tract infections (8.6%), nine gastrointestinal tract infections (4. 8%), 13 urinary tract infections (7.0%), eight port-associated infections (4.3%), six retropharyngeal and prevertebral infections (3.2%), 22 foreign body-associated infections (11.8%), three endocarditis of prosthetic valves (1, 6%), five odontogenic infections (2.7%), one infection attributable to immunodeficiency (0.5%), while in 50 patients (26.7%) the cause of infection remained unclear.
3.2. Diagnostic Sensitivity of Procedures
The highest sensitivity of pathogen detection was achieved using intraoperative specimens (162/208, 77.9%), followed by blood cultures (119/208, 57.2%) and being lowest at CT-guided biopsies (39/70, 55.7%, p = 0.012). The diagnostic sensitivity was 92.3% (192/208) for all procedures combined (Figure 2).
3.3. Diagnostic Sensitivity in SD and ISEE
Blood cultures demonstrated significantly higher diagnostic sensitivity for SD than for ISEE (SD: 91/142, 64.1% vs. ISEE: 28/66, 42.4%, p = 0.004). In contrast, the diagnostic sensitivity of intraoperative specimens was significantly higher in ISEE than in SD (SD: 102/142, 71.8% vs. ISEE: 59/66, 89.4%, p = 0.007). On the other hand, no difference in the sensitivity of CT-guided biopsy between both groups was observed (SD: 28/50, 56.0% vs. ISEE: 11/20, 55.0%, p = 1.0) (Figure 3).
3.4. Sensitivity under Ongoing Empiric Antibiotic Therapy
The diagnostic sensitivity of all three procedures combined was significantly higher in SD patients with postoperative TAT than in SD patients with EAT (EAT: 77/89, 86.5% vs. TAT: 53/53, 100%, p = 0.004). No such effect was observed in patients with ISEE (EAT: 47/51, 92.2% vs. TAT: 15/15, 100%, p = 0.567). Blood cultures, intraoperative specimens and CT-guided biopsies showed no significant difference in SD and ISEE in terms of sensitivity to the timing of antibiotic administration (Table 2). Intraoperative specimen showed the best diagnostic sensitivity in all groups (TAT-SD: 81.1%, TAT-ISEE: 86.7%, EAT-SD: 67.4%, and EAT-ISEE: 90.2%).
Table 2.
Infection Subgroup | All Three Procedures | Blood Cultures | Intraoperative Specimens | CT-Guided Biopsies |
---|---|---|---|---|
SD with TAT | 53/53 (100%) | 35/53 (66.0%) | 43/53 (81.1%) | 11/22 (50%) |
SD with ongoing EAT | 77/89 (86.5%) | 56/89 (62.9%) | 60/89 (67.4%) | 17/28 (66.7%) |
p-value * | 0.004 | 0.722 | 0.084 | 0.568 |
ISEE with TAT | 15/15 (100%) | 7/15 (46.7%) | 13/15 (86.7%) | 4/5 (80%) |
ISEE with ongoing EAT | 47/51 (92.2%) | 21/51 (41.2%) | 46/51 (90.2%) | 7/15 (46.7%) |
p-value * | 0.567 | 0.771 | 0.653 | 0.319 |
ISEE: isolated spinal epidural empyema, SD: spondylodiscitis, CT: computer tomography, EAT: empiric antibiotic therapy, TAT: targeted antibiotic therapy, *: Fisher exact test. Bold values are significant results (p < 0.05) as indicated in the methods.
3.5. Sensitivity of Single Procedure in SD and ISEE Patient Treated with EAT or TAT
The pathogen could always be isolated in the SD- and ISEE-TAT groups, with blood culture, intraoperative specimen, and CT-guided biopsy as single procedure showing no significant difference between SD and ISEE. In contrast, we observed a difference between the SD- and ISEE-EAT groups. The diagnostic sensitivity of blood culture alone was higher in the SD-EAT than in the ISEE-EAT (SD-EAT: 14/89, 18.2% vs. ISEE-EAT: 1/51, 2.1%, p = 0.010). The ISEE-EAT group showed better sensitivity than SD-EAT for intraoperative specimen (SD-EAT: 19/89, 24.7% vs. ISEE-EAT: 24/51, 51.1%, p = 0.002). CT-guided biopsy revealed no difference between the two groups (SD-EAT: 2/89, 2.6% vs. ISEE-EAT: 0/51, 0.0%, p = 0.534) (Table 3).
Table 3.
Procedure of Pathogen Detection | TAT | EAT | ||||
---|---|---|---|---|---|---|
SD | ISEE | p-Value * | SD | ISEE | p-Value * | |
Exclusively blood culture | 8/53 (15.1) | 2/15 (13.3) | 1.0 | 14/89 (18.2%) | 1/51 (2.1%) | 0.010 |
Exclusively intraoperative specimens | 15/53 (28.3) | 7/15 (46.7%) | 0.218 | 19/89 (24.7%) | 24/51 (51.1%) | 0.002 |
Exclusively CT-guided Biopsy | 0/53 (0.0%) | 0/15 (0.0%) | --- | 2/89 (2.6%) | 0/51 (0.0%) | 0.534 |
More than one procedure | 30/53 (56.6%) | 6/15 (40.0%) | 0.380 | 42/89 (54.5%) | 22/51 (46.8%) | 0.725 |
Unknown pathogens | 0 | 0 | 12 | 4 |
ISEE: isolated spinal epidural empyema, SD: spondylodiscitis, CT: computer tomography, EAT: empiric antibiotic therapy, TAT: targeted antibiotic therapy, *: Fisher exact test. Bold values are significant results (p < 0.05) as indicated in the methods.
3.6. The First Result of Detected Pathogen in SD and ISEE Treated with EAT or TAT
The first result of pathogen detection from blood culture, intraoperative specimen, and CT-guided biopsy showed no significant differences between SD and ISEE treated with TAT, but pathogens were always detected. The result of the first pathogen isolation in the EAT group was different between ISEE and SD. Blood culture in SD (SD-EAT: 50/89, 64.9% vs. ISEE-EAT: 18/51, 38.3%) and intraoperative specimen in ISEE (SD-EAT: 24/89, 31.2% vs. ISEE-EAT: 28/51, 59.6%, p = 0.008) played the most important role. CT-guided biopsy showed no differences between the two groups (SD-EAT: 3/89, 3.9% vs. ISEE-EAT: 1/51, 2.1%) (Table 4).
Table 4.
Procedure of First Pathogen Detection | TAT | EAT | ||||
---|---|---|---|---|---|---|
SD | ISEE | p-Value * | SD | ISEE | p-Value * | |
Blood culture | 31/53 (58.5%) | 6/15 (40%) | 0.340 | 50/89 (64.9%) | 18/51 (38.3%) | 0.008 |
Intraoperative specimens | 21/53 (39.6%) | 8/1 (53.3%) | 24/89 (31.2%) | 28/51 (59.6%) | ||
CT-guided Biopsy | 1/53 (1.9%) | 1/15 (6.7%) | 3/89 (3.9%) | 1/51 (2.1%) | ||
Unknown pathogens | 0 | 0 | 12 | 4 |
ISEE: isolated spinal epidural empyema, SD: spondylodiscitis, CT: computer tomography, EAT: empiric antibiotic therapy, TAT: targeted antibiotic therapy, *: Fisher exact test. Bold values are significant results (p < 0.05) as indicated in the methods.
3.7. The role of Each Procedure in Pathogen Detection in Both Entities
To determine which procedure as stand-alone was able to detect the most pathogens, we analyzed pathogen detection for all procedures in both subgroups, considering each procedure separately and in combination with others.
3.7.1. Spondylodiscitis
A quarter of pathogens were detected exclusively by intraoperative specimens (34/130, 26.2%), while 16.9% (22/130) were identified solely by blood cultures (p < 0.142). Only 1.5% (2/130) were detected by CT-guided biopsy. Over half of the pathogens (72/130, 55.4%) were found in more than one procedure (Figure 4).
3.7.2. Isolated Spinal Epidural Empyema
Half of the pathogens (31/62, 50%) were exclusively detected by intraoperative specimens, while only 4.5% (3/62) were detected by blood cultures (p < 0.001) and none were detected by CT-guided biopsy. Less than half of the pathogens were detected in more than one procedure (28/62, 45.2%) (Figure 5).
3.8. The First Result of Antibiogram and Resistogram from All Procedures
The time required to detect pathogens in blood cultures from blood and for intraoperative specimens from pus, tissue, or bone is different. In clinical practice, the results of all procedures (CT-guided biopsy, intraoperative specimen, and blood culture) are not available at the same time to the physician performing the procedure, however, the first result is the most important and provides the antibiogram and resistogram for initiating and switching antibiotic therapy. In this context, the comparison between intraoperative specimen and blood culture is relevant, since both procedures were performed on the same day in our center. There is a predicted delay in CT-guided biopsy, which was usually performed one or two days after surgery.
3.8.1. Spondylodiscitis
The first results were obtained in 62.3% (n = 81) from blood cultures, in 34.6% from intraoperative specimens (n = 45) and in 3.1% (n= 4) from CT-guided biopsies (p < 0.001) (Figure 6).
3.8.2. Isolated Spinal Epidural Empyema
The first results (36 cases) were obtained from intraoperative specimens in 58.1%, from blood cultures in 38.7% (n = 24) and from CT-guided biopsies in 3.2% (n = 2) (p < 0.001) (Figure 7).
4. Discussion
The main finding of our retrospective observational study is that intraoperative specimens demonstrate the highest diagnostic sensitivity for ISEE, whereas blood cultures show superior sensitivity in detecting pathogens in patients with SD. Interestingly, ongoing antibiotic treatment only affected the sensitivity of these tests in SD patients, with no significant effect on diagnostic yield in ISEE.
Consistent with previous studies, male patients were diagnosed with SD and ISEE twice as often as females in our cohort [5,16]. Gram-positive pathogens were identified in 86.6% of pyogenic infections, which is in line with the literature data ranging from 74 to 82% [21,22,23]. Our antibiotic management was based on the IDSA guidelines [18]. The mortality rate in our cohort was 6%, which is comparable to previous studies [16]. Moreover, our pathogen detection rate of 92.3% using all three diagnostic procedures combined is in accordance with the results of previous observational studies that detected pathogens in 67% and 100% of cases [4,16,24,25]. Authors have reported divergent diagnostic sensitivity of blood culture, image-guided biopsy, and intraoperative specimen for SD and ISEE (Table 5) [4,12,16,17,25,26,27,28,29,30,31,32,33,34,35,36].
Table 5.
Author | Blood Culture | Image-Guided Biopsy | Intraoperative Specimen |
---|---|---|---|
Vettivel et al. [37] | 37 (48.7%) | 30/40 (75%) * | |
Heuer et al. [38] | 145/307 (47%) | 213/307 (64%) * | |
Widdrington et al. [25] | 40/78 (51%) | 21/29 (72%) | 25/38 (66%) |
Hasan et al. [39] | 17/40 (42.5%) | 33/40 (82.5%) | NR |
Stangenberg et al. [34] | 97/182 (53.3%) | NR | 134/202 (66.3%) |
Nolla et al. [12] | 46/64 (63.4%) | 11/21 (52%) | 15/20 (75%) |
Colmenero et al. [28] | 52/152 (34.2%) | NR | NR |
Pigrau et al. [40] | 71/91 (78%) | NR | NR |
McHenry et al. [17] | 156/255 (61.2%) | 86/124 (69.4%) | 88/113 (77.9%) |
Patzakis et al. [33] | 13/26 (50%) | NR | NR |
Zarrouk et al. [36] | 14/29 (48.3%) | 11/15 (73.4%) | NR |
Carragee et al. [27] | 66/111 (59.5%) | NR | NR |
Ledermann et al. [30] | 25/41 (61%) | NR | NR |
Bateman et al. [26] | 23/52 (44.2%) | NR | 24/32 (75%) |
Torda et al. [35] | 10/16 (62.5%) | NR | NR |
Osenbach et al. [32] | 12/40 (30%) | NR | NR |
Hadjipavlou et al. [29] | NR | 19/26 (73.1%) | 25/40 (62.5%) |
Nather et al. [31] | 5/9 (55.6%) | NR | 14/16 (87.5%) |
Current study | 119/208 (57%) | 39/70 (56%) | 162/208 (78%) |
NR: not reported. *: The authors did not distinguish between image-guided biopsy and intraoperative specimen.
The diagnostic sensitivity of blood cultures in SD and ISEE patients varies widely from 30% to 78% according to previously published reports [12,16,17,24,25,26,27,28,30,31,32,33,34,35,36,37,38,39,40]. However, a systematic review of 14 clinical retrospective studies found that blood cultures routinely obtained in 91% of cases had an average sensitivity of 58%, which is consistent with our results (57.2%) [16]. The diagnostic sensitivity of image-guided biopsy ranges from 44.1% to 82.5% and can be increased by using different techniques such as X-ray or CT for sampling and different sites such as psoas, disc, or vertebral body [12,17,24,25,29,36,37,38,39]. Consistent with this spectrum, we were able to detect a pathogen with CT-guided biopsies from psoas abscess in 55.7% of cases.
Intraoperative specimens yielded the best results in the literature ranging from 59.6% to 87.5% [12,17,24,25,26,29,31,34,37,38]. Similarly, using this procedure, we were able to detect a pathogen in 77.9% of patients.
Data on the diagnostic sensitivity of all procedures in SD and ISEE are limited in the literature. The diagnostic sensitivity of blood cultures and intraoperative specimens differed between SD and ISEE. Blood culture sensitivity was higher in SD, whereas intraoperative specimen sensitivity was higher in ISEE. This supports the assumption that SD is mainly a hematogenous dissemination, whereas ISEE is a local encapsulated mass with pus or inflammatory tissue, which can ideally be reached by intraoperative sampling.
Previous studies have shown that blood cultures can detect pathogens in 57.2% of cases, with even higher rates up to 70% in antibiotic-naive patients [4,12,16]. In our study, the sensitivity of all three methods was significantly lower in SD patients under ongoing EAT than in SD patients without antibiotics, whereas the sensitivity in ISEE showed no significant difference in relation to antibiotic therapy.
The diagnostic sensitivity of the stand-alone procedure showed no differences between SD and ISEE when the patient was treated with TAT, whereas the EAT group differed in terms of blood culture as the most sensitive stand-alone procedure in SD and intraoperative specimen in ISEE. Our study also showed the same results in terms of the first result of pathogen detection in SD and ISEE patients treated with TAT or EAT.
In our cohort, pathogen detection in ISEE was higher in intraoperative specimens exclusively compared with blood cultures (50% versus 5%), demonstrating the importance of surgical sampling in ISEE. This was not significant in SD. The first decisive result of pathogen detection in SD patients was achieved in 62.3% of cases by blood culture and in 58.1% of cases of ISEE by the intraoperative specimen in our study. Therefore, blood cultures in SD and intraoperative samples in ISEE seem to be of the highest importance to allow the administration of targeted antibiotics.
CT-guided biopsy was performed only in the psoas abscess but not in the disc compartment in SD or in the epidural empyema in ISEE, where infectious processes usually occur, which may have influenced our results. The results of a CT-guided biopsy for pathogen detection varies and depends on the examination technique, the examiner, patient collective, and the specimen being collected. Numerous other factors, including laboratory parameters (C-reactive protein > 50 mg/L), CT features (nonsclerotic endplate erosions), and magnetic resonance criteria (paravertebral/epidural abscess formation), appeared to be associated with positive pathogen detection [41].
For specific anatomic structures, such as the psoas, CT-guided biopsy with drainage is essential because of the percutaneous minimally invasive technique and success rate in targeting, as well as the low complication rate. In addition, CT-guided biopsy is an essential procedure in patients without instability or neurologic deficits due to the avoidance of surgery with potential complications despite the anesthetic and healing disruption risks. The above demonstrates how important CT-guided biopsy is for the treatment of SD and ISEE. The poorly presented results of CT-guided biopsy in this study compared with blood culture and intraoperative specimen may be influenced by the selective surgical patient, timing of the procedure, and anatomic structure of the collection (psoas abscess only). Nevertheless, this study demonstrated favorable diagnostic sensitivity for CT-guided biopsy compared with the existing literature, which suggested a successful pathogen detection rate ranging from 28.1% to 57.1% [42,43], and provided a novel comparison of all three procedures with limitations.
Limitations and Strengths of This Study
This study has inherent limitation due to its retrospective nature. However, our findings provide valuable insights into the diagnostic sensitivity of blood cultures, intraoperative specimens, and CT-guided biopsies and serve a basis for prospective research. The monocentric design of our study limits the generalizability of our observations. Nevertheless, our cohort of SD and ISEE patients underwent comprehensive phenotyping, including, detailed demographic, clinical, radiological, laboratory and microbiological assessments, which enhances the internal validity of our data. To confirm our findings and assess their external validity, well-designed multicentric studies are needed, preferably in a prospective interventional setting [44].
5. Conclusions
To achieve the best diagnostic sensitivity for causative pathogens, all procedures are essential, particularly intraoperative specimens and blood cultures. Intraoperative specimens yielded the highest single result, followed by blood cultures. However, blood cultures remain crucial due to their non-invasive nature. Blood cultures are crucial for identifying pathogens in SD, while intraoperative specimens are essential for isolating pathogens in ISEE.
Blood cultures play the most important role in pathogen identification in SD, while intraoperative specimens are leading in the description of pathogens in ISEE. Without surgical intervention, nearly half of the pathogens in ISEE patients cannot be detected. This study reveals that the combined diagnostic procedures have lower sensitivity in SD patients with ongoing EAT, but not in ISEE patients.
Author Contributions
M.M.H.: conceptualization, methodology, software, validation, formal analysis, investigation, resources, data curation, writing—original draft preparation, project administration, and funding acquisition. I.Y.E., T.A.J., D.P., A.C.D., U.P., T.S. and M.M.H.: writing—review and editing, visualization, and supervision. All authors have read and agreed to the published version of the manuscript.
Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of the local ethics committee at the University Hospital Dresden (protocol code: BO-EK-17012022, January 2022).
Informed Consent Statement
Patient consent was waived due to the retrospective, anonymous character of this study.
Data Availability Statement
The original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author.
Acknolegdment
We would like to thank Gabriele Schackert and Kay Engellandt for their support.
Conflicts of Interest
The authors declare no conflict of interest.
Funding Statement
This research received no external funding.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
References
- 1.Butler J.S., Shelly M.J., Timlin M., Powderly W.G., O’Byrne J.M. Nontuberculous pyogenic spinal infection in adults: A 12-year experience from a tertiary referral center. Spine. 2006;31:2695–2700. doi: 10.1097/01.brs.0000244662.78725.37. [DOI] [PubMed] [Google Scholar]
- 2.Frangen T.M., Kalicke T., Gottwald M., Andereya S., Andress H.J., Russe O.J., Muller E.J., Muhr G., Schinkel C. Die operative Therapie der Spondylodiszitis. Unfallchirurg. 2006;109:743–753. doi: 10.1007/s00113-006-1084-7. [DOI] [PubMed] [Google Scholar]
- 3.Tsiodras S., Falagas M.E. Clinical assessment and medical treatment of spine infections. Clin. Orthop. Relat. Res. 2006;444:38–50. doi: 10.1097/01.blo.0000203454.82264.cd. [DOI] [PubMed] [Google Scholar]
- 4.Herren C., Jung N., Pishnamaz M., Breuninger M., Siewe J., Sobottke R. Spondylodiscitis: Diagnosis and Treatment Options. Dtsch. Arztebl. Int. 2017;114:875–882. doi: 10.3238/arztebl.2017.0875. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Zarghooni K., Rollinghoff M., Sobottke R., Eysel P. Treatment of spondylodiscitis. Int. Orthop. 2012;36:405–411. doi: 10.1007/s00264-011-1425-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Rosc-Bereza K., Arkuszewski M., Ciach-Wysocka E., Boczarska-Jedynak M. Spinal epidural abscess: Common symptoms of an emergency condition. A case report. Neuroradiol. J. 2013;26:464–468. doi: 10.1177/197140091302600411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Quack V., Hermann I., Rath B., Dietrich K., Spreckelsen C., Luring C., Arbab D., Mueller C.A., Shousha M., Clusmann H., et al. Current treatment strategies for spondylodiscitis in surgical clinics in Germany. Z. Orthop. Unfall. 2014;152:577–583. doi: 10.1055/s-0034-1383131. [DOI] [PubMed] [Google Scholar]
- 8.Rustemi O., Raneri F., Alvaro L., Gazzola L., Beggio G., Rossetto L., Cervellini P. Single-approach vertebral osteosynthesis in the treatment of spinal osteolysis by spondylodiscitis. Neurosurg. Focus. 2019;46:E9. doi: 10.3171/2018.10.FOCUS18442. [DOI] [PubMed] [Google Scholar]
- 9.Decker S., Schroder B.M., Stubig T., Sehmisch S. Common infectious challenges of the thoracic and lumbar spine: Spondylodiscitis and postoperative wound infection. Unfallchirurg. 2022;125:33–40. doi: 10.1007/s00113-021-01108-1. [DOI] [PubMed] [Google Scholar]
- 10.Cunha B.A. Osteomyelitis in elderly patients. Clin. Infect. Dis. 2002;35:287–293. doi: 10.1086/341417. [DOI] [PubMed] [Google Scholar]
- 11.Nagashima H., Tanishima S., Tanida A. Diagnosis and management of spinal infections. J. Orthop. Sci. 2018;23:8–13. doi: 10.1016/j.jos.2017.09.016. [DOI] [PubMed] [Google Scholar]
- 12.Nolla J.M., Ariza J., Gomez-Vaquero C., Fiter J., Bermejo J., Valverde J., Escofet D.R., Gudiol F. Spontaneous pyogenic vertebral osteomyelitis in nondrug users. Semin. Arthritis Rheum. 2002;31:271–278. doi: 10.1053/sarh.2002.29492. [DOI] [PubMed] [Google Scholar]
- 13.Nickerson E.K., Sinha R. Vertebral osteomyelitis in adults: An update. Br. Med. Bull. 2016;117:121–138. doi: 10.1093/bmb/ldw003. [DOI] [PubMed] [Google Scholar]
- 14.Pingel A. Spondylodiscitis. Z. Orthop. Unfall. 2021;159:687–703. doi: 10.1055/a-1129-9246. [DOI] [PubMed] [Google Scholar]
- 15.Fleege C., Wichelhaus T.A., Rauschmann M. Systemic and local antibiotic therapy of conservative and operative treatment of spondylodiscitis. Orthopade. 2012;41:727–735. doi: 10.1007/s00132-012-1920-0. [DOI] [PubMed] [Google Scholar]
- 16.Mylona E., Samarkos M., Kakalou E., Fanourgiakis P., Skoutelis A. Pyogenic vertebral osteomyelitis: A systematic review of clinical characteristics. Semin. Arthritis Rheum. 2009;39:10–17. doi: 10.1016/j.semarthrit.2008.03.002. [DOI] [PubMed] [Google Scholar]
- 17.McHenry M.C., Easley K.A., Locker G.A. Vertebral osteomyelitis: Long-term outcome for 253 patients from 7 Cleveland-area hospitals. Clin. Infect. Dis. 2002;34:1342–1350. doi: 10.1086/340102. [DOI] [PubMed] [Google Scholar]
- 18.Berbari E.F., Kanj S.S., Kowalski T.J., Darouiche R.O., Widmer A.F., Schmitt S.K., Hendershot E.F., Holtom P.D., Huddleston P.M., 3rd, Petermann G.W., et al. Executive Summary: 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults. Clin. Infect. Dis. 2015;61:859–863. doi: 10.1093/cid/civ633. [DOI] [PubMed] [Google Scholar]
- 19.Chandnani V.P., Beltran J., Morris C.S., Khalil S.N., Mueller C.F., Burk J.M., Bennett W.F., Shaffer P.B., Vasila M.S., Reese J., et al. Acute experimental osteomyelitis and abscesses: Detection with MR imaging versus CT. Radiology. 1990;174:233–236. doi: 10.1148/radiology.174.1.2294554. [DOI] [PubMed] [Google Scholar]
- 20.Parikh R., Mathai A., Parikh S., Chandra Sekhar G., Thomas R. Understanding and using sensitivity, specificity and predictive values. Indian. J. Ophthalmol. 2008;56:45–50. doi: 10.4103/0301-4738.37595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Bernard L., Dinh A., Ghout I., Simo D., Zeller V., Issartel B., Le Moing V., Belmatoug N., Lesprit P., Bru J.P., et al. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: An open-label, non-inferiority, randomised, controlled trial. Lancet. 2015;385:875–882. doi: 10.1016/S0140-6736(14)61233-2. [DOI] [PubMed] [Google Scholar]
- 22.Fragio Gil J.J., Gonzalez Mazario R., Salavert Lleti M., Roman Ivorra J.A. Vertebral osteomyelitis: Clinical, microbiological and radiological characteristics of 116 patients. Med. Clin. 2020;155:335–339. doi: 10.1016/j.medcli.2019.12.029. [DOI] [PubMed] [Google Scholar]
- 23.Kehrer M., Pedersen C., Jensen T.G., Hallas J., Lassen A.T. Increased short- and long-term mortality among patients with infectious spondylodiscitis compared with a reference population. Spine J. 2015;15:1233–1240. doi: 10.1016/j.spinee.2015.02.021. [DOI] [PubMed] [Google Scholar]
- 24.Pola E., Taccari F., Autore G., Giovannenze F., Pambianco V., Cauda R., Maccauro G., Fantoni M. Multidisciplinary management of pyogenic spondylodiscitis: Epidemiological and clinical features, prognostic factors and long-term outcomes in 207 patients. Eur. Spine J. 2018;27:229–236. doi: 10.1007/s00586-018-5598-9. [DOI] [PubMed] [Google Scholar]
- 25.Widdrington J.D., Emmerson I., Cullinan M., Narayanan M., Klejnow E., Watson A., Ong E.L.C., Schmid M.L., Price D.A., Schwab U., et al. Pyogenic Spondylodiscitis: Risk Factors for Adverse Clinical Outcome in Routine Clinical Practice. Med. Sci. 2018;6:96. doi: 10.3390/medsci6040096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Bateman J.L., Pevzner M.M. Spinal osteomyelitis: A review of 10 years’ experience. Orthopedics. 1995;18:561–565. doi: 10.3928/0147-7447-19950601-10. [DOI] [PubMed] [Google Scholar]
- 27.Carragee E.J. Pyogenic vertebral osteomyelitis. J. Bone Joint Surg. Am. 1997;79:874–880. doi: 10.2106/00004623-199706000-00011. [DOI] [PubMed] [Google Scholar]
- 28.Colmenero J.D., Jimenez-Mejias M.E., Sanchez-Lora F.J., Reguera J.M., Palomino-Nicas J., Martos F., Garcia de las Heras J., Pachon J. Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: A descriptive and comparative study of 219 cases. Ann. Rheum. Dis. 1997;56:709–715. doi: 10.1136/ard.56.12.709. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Hadjipavlou A.G., Mader J.T., Necessary J.T., Muffoletto A.J. Hematogenous pyogenic spinal infections and their surgical management. Spine. 2000;25:1668–1679. doi: 10.1097/00007632-200007010-00010. [DOI] [PubMed] [Google Scholar]
- 30.Ledermann H.P., Schweitzer M.E., Morrison W.B., Carrino J.A. MR imaging findings in spinal infections: Rules or myths? Radiology. 2003;228:506–514. doi: 10.1148/radiol.2282020752. [DOI] [PubMed] [Google Scholar]
- 31.Nather A., David V., Hee H.T., Thambiah J. Pyogenic vertebral osteomyelitis: A review of 14 cases. J. Orthop. Surg. 2005;13:240–244. doi: 10.1177/230949900501300305. [DOI] [PubMed] [Google Scholar]
- 32.Osenbach R.K., Hitchon P.W., Menezes A.H. Diagnosis and management of pyogenic vertebral osteomyelitis in adults. Surg. Neurol. 1990;33:266–275. doi: 10.1016/0090-3019(90)90047-S. [DOI] [PubMed] [Google Scholar]
- 33.Patzakis M.J., Rao S., Wilkins J., Moore T.M., Harvey P.J. Analysis of 61 cases of vertebral osteomyelitis. Clin. Orthop. Relat. Res. 1991;264:178–183. doi: 10.1097/00003086-199103000-00019. [DOI] [PubMed] [Google Scholar]
- 34.Stangenberg M., Mende K.C., Mohme M., Kratzig T., Viezens L., Both A., Rohde H., Dreimann M. Influence of microbiological diagnosis on the clinical course of spondylodiscitis. Infection. 2021;49:1017–1027. doi: 10.1007/s15010-021-01642-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Torda A.J., Gottlieb T., Bradbury R. Pyogenic vertebral osteomyelitis: Analysis of 20 cases and review. Clin. Infect. Dis. 1995;20:320–328. doi: 10.1093/clinids/20.2.320. [DOI] [PubMed] [Google Scholar]
- 36.Zarrouk V., Feydy A., Salles F., Dufour V., Guigui P., Redondo A., Fantin B. Imaging does not predict the clinical outcome of bacterial vertebral osteomyelitis. Rheumatology. 2007;46:292–295. doi: 10.1093/rheumatology/kel228. [DOI] [PubMed] [Google Scholar]
- 37.Vettivel J., Bortz C., Passias P.G., Baker J.F. Pyogenic Vertebral Column Osteomyelitis in Adults: Analysis of Risk Factors for 30-Day and 1-Year Mortality in a Single Center Cohort Study. Asian Spine J. 2019;13:608–614. doi: 10.31616/asj.2018.0295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Heuer A., Strahl A., Viezens L., Koepke L.G., Stangenberg M., Dreimann M. The Hamburg Spondylodiscitis Assessment Score (HSAS) for Immediate Evaluation of Mortality Risk on Hospital Admission. J. Clin. Med. 2022;11:660. doi: 10.3390/jcm11030660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Hasan G.A., Raheem H.Q., Qutub A., Wais Y.B., Katran M.H., Shetty G.M. Management of Pyogenic Spondylodiscitis Following Nonspinal Surgeries: A Tertiary Care Center Experience. Int. J. Spine Surg. 2021;15:591–599. doi: 10.14444/8080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Pigrau C., Almirante B., Flores X., Falco V., Rodriguez D., Gasser I., Villanueva C., Pahissa A. Spontaneous pyogenic vertebral osteomyelitis and endocarditis: Incidence, risk factors, and outcome. Am. J. Med. 2005;118:1287. doi: 10.1016/j.amjmed.2005.02.027. [DOI] [PubMed] [Google Scholar]
- 41.Braun A., Germann T., Wunnemann F., Weber M.A., Schiltenwolf M., Akbar M., Burkholder I., Kauczor H.U., Rehnitz C. Impact of MRI, CT, and Clinical Characteristics on Microbial Pathogen Detection Using CT-Guided Biopsy for Suspected Spondylodiscitis. J. Clin. Med. 2019;9:32. doi: 10.3390/jcm9010032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Michel S.C., Pfirrmann C.W., Boos N., Hodler J. CT-guided core biopsy of subchondral bone and intervertebral space in suspected spondylodiskitis. AJR Am. J. Roentgenol. 2006;186:977–980. doi: 10.2214/AJR.05.0109. [DOI] [PubMed] [Google Scholar]
- 43.Rieneck K., Hansen S.E., Karle A., Gutschik E. Microbiologically verified diagnosis of infectious spondylitis using CT-guided fine needle biopsy. APMIS. 1996;104:755–762. doi: 10.1111/j.1699-0463.1996.tb04939.x. [DOI] [PubMed] [Google Scholar]
- 44.Spieth P.M., Kubasch A.S., Penzlin A.I., Illigens B.M., Barlinn K., Siepmann T. Randomized controlled trials—A matter of design. Neuropsychiatr. Dis Treat. 2016;12:1341–1349. doi: 10.2147/NDT.S101938. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author.